These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16300987)

  • 1. Statins in rheumatology.
    Soubrier M; Roux C
    Joint Bone Spine; 2006 Mar; 73(2):159-68. PubMed ID: 16300987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
    Danninger K; Hoppe UC; Pieringer H
    Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in rheumatology.
    Penney CJ
    J Rheumatol; 2005 Jan; 32(1):17-9. PubMed ID: 15630718
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.
    Bisoendial RJ; Stroes ES; Kastelein JJ; Tak PP
    Nat Rev Rheumatol; 2010 Mar; 6(3):157-64. PubMed ID: 20142814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.
    Lee JM; Choudhury RP
    Nat Rev Rheumatol; 2010 Mar; 6(3):123-4. PubMed ID: 20197773
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential antiinflammatory and immunomodulatory effects of statins in rheumatologic therapy.
    Arnaud C; Mach F
    Arthritis Rheum; 2006 Feb; 54(2):390-2. PubMed ID: 16447215
    [No Abstract]   [Full Text] [Related]  

  • 7. The pleiotropic effects of statins in rheumatoid arthritis.
    Aminifar E; Tavakkol Afshari HS; Sathyapalan T; Abbasifard M; Sahebkar A
    J Pharm Pharmacol; 2023 Jul; 75(7):910-920. PubMed ID: 37027319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?
    Abeles AM; Pillinger MH
    Arthritis Rheum; 2006 Feb; 54(2):393-407. PubMed ID: 16447216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statins as possible therapeutic tools for osteoporosis].
    Takeuchi Y; Takeda S
    Clin Calcium; 2004 Feb; 14(2):302-7. PubMed ID: 15576989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and rheumatoid arthritis.
    Bhatia GS; Sosin MD; Connolly DL; Davis RC
    Lancet; 2004 Nov 20-26; 364(9448):1853; author reply 1855. PubMed ID: 15555660
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.
    Navarro-Millán I; Goyal P; Safford MM
    Rheumatology (Oxford); 2019 Jun; 58(6):933-934. PubMed ID: 30272226
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular disease and osteoporosis: is there a link between lipids and bone?
    Burnett JR; Vasikaran SD
    Ann Clin Biochem; 2002 May; 39(Pt 3):203-10. PubMed ID: 12038594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins--are they potentially useful in rheumatology?].
    Bielinska A; Gluszko P
    Pol Arch Med Wewn; 2007 Sep; 117(9):420-5. PubMed ID: 18062565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins in rheumatoid arthritis--two birds with one stone?
    Klareskog L; Hamsten A
    Lancet; 2004 Jun; 363(9426):2011-2. PubMed ID: 15207947
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
    Pham T; Gossec L; Constantin A; Pavy S; Bruckert E; Cantagrel A; Combe B; Flipo RM; Goupille P; Le Loët X; Mariette X; Puéchal X; Schaeverbeke T; Sibilia J; Tebib J; Wendling D; Dougados M
    Joint Bone Spine; 2006 Jul; 73(4):379-87. PubMed ID: 16690341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determining cardiovascular risk in patients with rheumatoid arthritis: waiting for trial outcomes is not recommended].
    Nurmohamed MT
    Ned Tijdschr Geneeskd; 2011; 155(29):A3485. PubMed ID: 21791135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are statins of value in therapy of osteoporosis?].
    Gosch M
    Wien Med Wochenschr; 2003; 153(11-12):255-7. PubMed ID: 12879634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?
    Toms TE; Panoulas VF; Douglas KM; Griffiths H; Sattar N; Smith JP; Symmons DP; Nightingale P; Metsios GS; Kitas GD
    Ann Rheum Dis; 2010 Apr; 69(4):683-8. PubMed ID: 19854705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.